Immunosuppression in children with malaria.
D000208:Acute Disease; D000818:Animals; D000917:Antibody Formation; D000941:Antigens; D002051:Burkitt Lymphoma / Q000209:etiology; D002175:Candida / Q000276:immunology; D002648:Child; D004195:Disease Models, Animal; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007118:Immunoassay; D007165:Immunosuppression Therapy; D066298:In Vitro Techniques; D037102:Lectins; D008213:Lymphocyte Activation; D008288:Malaria / Q000150:complications / Q000276:immunology*; D051379:Mice; D009578:Nitrobenzenes; D012882:Skin Tests; D013291:Streptococcus / Q000276:immunology; D013745:Tetanus Toxoid; D013936:Thymidine; D014316:Tritium; D014373:Tuberculin; D014436:Typhoid-Paratyphoid Vaccines
D000941:Antigens; D037102:Lectins; D009578:Nitrobenzenes; D013745:Tetanus Toxoid; D014373:Tuberculin; D014436:Typhoid-Paratyphoid Vaccines; D014316:Tritium; D013936:Thymidine